Skip to main content
. 2020 Dec 15;10:22011. doi: 10.1038/s41598-020-78886-y

Figure 1.

Figure 1

TREK-1 activation with the novel compounds ML335 and BL1249 protects form HO-induced lung injury: (A) Representative images of H&E-stained lung sections of WT mice exposed to either room air (panels a-c) or HO (panels d-f) for 72 h. All mice received once-daily, intra-tracheal (i.t.) injections of ML335, BL1249, or a vehicle control (no drugs) via brief endotracheal intubation. HO exposure caused significant lung injury (panel d), which was ameliorated by concomitant treatment with ML335 or BL1249 (panels e, f). (B) Summary of cumulative Lung Injury Scores of n = 5 independent experiments. (CE) The HO-induced decrease in semi-static lung compliance, and increase in BAL fluid total protein and cell count were counteracted by ML335 and BL1249. Data are represented as Box-Whisker plots with medians, 1st and 3rd quartiles, and max and min values; n = 5–9; ^compared to mice injected with a vehicle control and exposed to room air (no drugs), *compared to HO exposed mice; p ≤ 0.05.